Genitourinary Radiology

The rise of theranostics: Part 2 -- Moving into communities
By Liz Carey
In part 2 of The Rise of theranostics series, experts weigh in on getting started in prostate cancer theranostics as some private urology, radiation oncology practices, and radiologist groups begin building their abilities.
April 4, 2024
Theranostics with Thomas Hope, MD, University of California, San Francisco (UCSF)
GEHC launches AI software for prostate imaging
By AuntMinnie.com staff writers
GE HealthCare (GEHC) has launched AI-enabled software for ultrasound imaging systems called Prostate Volume Assist designed to automate the manual process for generating prostate volume measurements.
March 27, 2024
Prostate Cancer
Can fetal ultrasound lead to better handling of chromosomal anomalies?
By Amerigo Allegretto
Ultrasonographic measurements of fetal nuchal translucency can lead to better management of chromosomal anomalies.
March 26, 2024
Fetal Ultrasound 400
Can ChatGPT-4 accurately interpret thyroid, renal ultrasound images?
By Amerigo Allegretto
In a small study, ChatGPT-4 demonstrated high accuracy in analyzing and interpreting thyroid and renal ultrasound images.
March 22, 2024
Ultrasound Throat 400
MRI/ultrasound combination effective for treating prostate cancer
By Kate Madden Yee
A new, minimally invasive procedure that combines MRI and transurethral ultrasound ablation is effective for treating prostate cancer, according to recent research.
March 21, 2024
Prostate Cancer
Protocols, resources can reduce CT use in child appendectomy patients
By Amerigo Allegretto
Developing protocols and having resources available are ways hospitals can limit radiation exposure from CT to pediatric appendectomy patients.
March 20, 2024
Appendix 400
Ultrasound model predicts liver disease progress
By Amerigo Allegretto
A predictive model combining multiple ultrasonic parameters can discriminate between different liver diseases.
March 20, 2024
Multiparametric ultrasound in a 52-year-old female patient with metabolic dysfunction-associated fatty liver disease (MAFLD) and hepatitis B, whose body mass index was 26.9. (A) Gray-scale image (left) shows the liver parenchyma, and attenuation image (right) shows the right liver lobe acquired from the right intercostal oblique plane, with the degree of attenuation color-coded in the sampling box. Orange indicates a high attenuation coefficient and blue indicates a low attenuation coefficient. The coefficient value (0.59 dB/cm/MHz) and reliability index (R2 = 0.95) are presented in the lower left corner. (B) 2D shear-wave elastography-generated quad-view mode image shows an elasticity map, propagation map, gray-scale image, and dispersion map at the same time. A 1-cm region of interest is placed within the sampling box of each image. Red and blue indicate high and low elasticity and dispersion slope, respectively. Liver stiffness on the elasticity map is 5.6 kPa, and the dispersion slope on the dispersion map is 13.23 (m/sec)/kHz. Image courtesy of the RSNA.
MRgFUS shows promise in treating prostate cancer
By Amerigo Allegretto
MRI-guided focused ultrasound (MRgFUS) therapy can successfully treat prostate cancer for those at intermediate risk.
March 7, 2024
Images depict biopsy-confirmed prostate cancer in a 56-year-old man. (A) Pretreatment axial T2-weighted fast spin-echo MRI scan and (B) apparent diffusion coefficient map acquired with a 3T scanner show the tumor in the left transition zone (arrows). (C) Intraoperative 1.5-T MRI scan shows the contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). (D) Intraoperative MRI scan shows a focused ultrasound beam path (blue) overlaid on the treatment plan. The rectangular boxes show each sonication spot. (E) Thermal map obtained during treatment shows heat deposition color-coded in red and overlaid on the sonication spot. (F) Axial gadobutrol-enhanced MRI scan obtained immediately after treatment shows the devascularized ablated volume (arrows). (G) Corresponding T2-weighted fast spin-echo 3T MRI scan obtained at 24 months after ablation shows fibrosis and volume loss in the left transition zone (arrows). Findings from a biopsy showed scar tissue, negative for malignancy at the treatment site.
PI-RADS optimizes MRI-based diagnostics for prostate cancer detection
By Kate Madden Yee
It's better to take Prostate Imaging-Reporting and Data System (PI-RADS) upgrading rules into account when it comes to deciding whether a patient with clinically significant prostate cancer needs a biopsy, researchers have reported.
February 15, 2024
Prostate Cancer
CT radiomics predict lymph node metastasis in bladder cancer patients
By Kate Madden Yee
A deep-learning model that combines CT radiomics and clinical information shows promise for predicting lymph node metastasis in bladder cancer patients, researchers have reported.
January 29, 2024
Bladder Cancer
PET/CT predicts adverse cardiac events in men with prostate cancer
By Will Morton
PET/CT scans used to visualize findings in men with recurrent prostate cancer may also help assess their risk for cardiovascular disease.
January 25, 2024
Heart Attack
Pluvicto prostate cancer treatment protocols vary globally
By Will Morton
An international survey of treatment centers has revealed significant differences in several aspects of Lu-177 PSMA-617 prostate cancer therapy.
January 23, 2024
Prostate
Page 1 of 90
Next Page